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Brain spectrinInteractions of two local anesthetics, dibucaine and tetracaine have been studied with phospholipid vesicles
containing cholesterol and/or monosialogangliosides (GM1) using ﬂuorescence spectroscopy. The ﬂuorescence
intensity of tetracaine showed a marked increase with the increasing molar ratio of the phospholipid to tetra-
caine, while that of dibucaine showed opposite effects. Steady state anisotropy and the wavelength of maximum
emission (λmax) decreased with the increasing phospholipids to tetracaine ratio. The extent of such changes in
anisotropy and λmax in the presence and absence of two important components of neuronal membranes,
cholesterol and GM1 indicated differential membrane localization of the two local anesthetics. To understand
the intercellular mode of action of local anesthetics, we have also studied the interactions of dibucaine and
tetracaine with brain spectrin which indicate differential spectrin interactions with similar binding strength.
Thermodynamic parameters associated with such binding reveal that binding is favored by entropy. Tetracaine
brings about distinct structural changes in spectrin compared to dibucaine, as reﬂected in the tryptophan
mean lifetime and far-UV CD spectra. Tetracaine also exhibits a detergent-like property inducing concentration
dependent decrease in spectrin anisotropy, further indicating structural changes in brain spectrin with probable
implications in its anesthetic potential.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Local anesthetics are known to produce loss of sensation in certain
areas of the body by blocking nerve transmissions via state dependent
binding of voltage-gated Na+ channels [1,2]. They have the potential
to cause serious harm if used without caution. Use of high doses of
local anesthetics may cause cardiovascular collapse (etidocaine,
bupivacaine, lidocaine) and irreversible nerve injury (lidocaine, tetra-
caine) due to its surfactant-like properties. The details of molecular
mechanisms by which local anesthetics block impulses in peripheral
nerves are well established. However, the overall mechanism for spinal
and epidural anesthesia and drug induced toxicity is still an unsolved
question [3–5]. Anesthetic action of local anesthetics in the peripheral
nervous system is caused by blocking the propagating action potentialoylphosphatidylcholine; DOPC,
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it1960@gmail.comthrough inhibition of voltage-gated sodium ion channels. Such inhibi-
tion results from the binding of local anesthetics within the cytoplasmic
domain of the channel protein. Local anesthetics bind to the pore region
S5–S6 transmembrane segments from all four pseudorepeated domains
of channel protein [6,7]. Binding of local anesthetics to these channels
depends on their conformationwith the drug, generally having a higher
afﬁnity for the open and inactivated state of the channels, induced by
membrane depolarization. In contrast with anesthesia in the peripheral
nervous system, the overall mechanism for spinal and epidural anesthe-
sia is more complex than simply blocking the impulses in nerve roots,
involving both pre- and post-synaptic receptors as well as intercellular
pathways. Delivery of local anesthetics to the spinal chord as well as
to spinal roots allows the possibility of altering both synaptic activity
and impulse conduction affecting the responses within the spinal
cord. Local anesthetics can also interact with membrane lipids, thereby
affecting the conformation of the drugs for presentation to a variety of
neuronal membrane channels and receptors, leading to clinical analge-
sia. The local anesthetics membrane interactions can thus modulate
sodium channels, favoring the inactivated state of the channel that is
essential for their anesthetic action governing clinical effectiveness.
Cholesterol is an essential component of eukaryotic cells and is
non-randomly distributed among the biological membranes [8,9]. Cho-
lesterol is themost representative sterol enriched in plasmamembrane.
822 A. Chakrabarti, M. Patra / Biochimica et Biophysica Acta 1848 (2015) 821–832The major function of cholesterol is to condense and order the polar
lipids, thereby thickening, stiffening and strengthening the bilayer
[10,11]. Cholesterol also maintains the lateral heterogeneity of lipid
and protein distribution in the plasma membrane and forms clusters
with other lipid components of membranes such as sphingolipids to
form rafts, playing a crucial role in signal transduction [12,13]. Ganglio-
sides, the most complex of glycosphingolipids, are abundant in the
plasma membrane of the nerve cells (making up 5–10% of the local
lipid mass) and show immense structural variations [14]. Gangliosides
are sialic acid containing glycolipid, formed by a hydrophobic ceramide
and a hydrophilic oligosaccharide chain. Nerve cell membranes are par-
ticularly rich in gangliosides which play an important role in signal
transduction and brain pathology through cell–cell interaction [15,16].
Gangliosides are also involved in many important events occurring at
the cell surface including binding of various antibodies, pericellular
adhesive protein, bacterial toxins and viruses to plasma membrane.
Gangliosides have been considered as an important component of
lipid microdomains or raft that mediated protein sorting, transport
and signal transduction [12,17,18].
The effects of local anesthetics on the organization of phospholipid bi-
layers and the motional constraints on the anesthetic molecule upon
binding to lipid membranes have been studied through several spectro-
scopic techniques [19–26]. Earlier studies have shown that the potency
of an anesthetic is proportional to its amphiphilic side chain [27–29].
Furthermore, it has been reported that the potency of an anesthetic is
not regulated by its hydrophobicity alone. Polar interactions and other
steric parameters also determine a speciﬁc or preferential localization of
each anesthetic molecule inside the membrane [30,31]. In addition, DSC
study indicates that local anesthetics can lower the phase transition
temperature and increase electrical conductance of the phospholipid
membrane by interacting with its hydrophilic head group region of
lipid bilayers [32–34]. One of the most studied tertiary amine local anes-
thetics, tetracaine (2-[diethylamino] ethyl-4-[butylamino]benzoate) and
dibucaine (2-butoxy-N-[2-diethylamino]-4-quinoline-carboxamide)
can assume several forms such as neutral base, hydrogen bonded,
monoprotonated, diprotonated species, depending upon the pH of the
solvent and the nature of the microenvironment. Tetracaine and
dibucaine are monoprotonated in water, in the range of pH 3–14. In hy-
drophobic environments, the deprotonated species prevails. Boulanger
and coworkers have shown, using 2H NMR, that charged tetracaine be-
haves like an inorganic ion and weakly bound charged anesthetics reside
in the membrane water interface. On the other hand, neutral anesthetic
molecules bind strongly to the membrane and penetrate deeply into the
core of the bilayer [20]. NMR spectroscopic studies supported bymolecu-
lar dynamics calculation indicate that tetracaine and dibucaine assume
more than two conformations and exist as dimers in phosphatidylcholine
(PC) vesicles [35]. In an earlier NMR study performed in pure PC vesicles
using deuterated anesthetics, multiple binding sites for tetracaine and
procaine were observed in phospholipid bilayers [22]. These studies also
indicated two states of binding for tetracaine: a weakly bounded state at
a low pH of 5.5 and a “strongly bound” state at a high pH of 9.5, signifying
the presence of two differently charged or aggregated species of the local
anesthetics. NMR and ﬂuorescence studies indicated dibucaine binding in
the vicinity of the phospholipid glycerol moiety [20,36]. Studies on depth
proﬁling by ﬂuorescence quenching and NMR investigation in different
membrane systems indicated the location of dibucaine and tetracaine to
be at a shallow position in the phospholipid bilayer [36–38]. NMR inves-
tigations have also been performed to study the interaction of tetracaine
with a PC-based membrane containing cholesterol [39].
Local anesthetics have also been shown to interact with many
membrane associated proteins other than the primary targets of Na+
channel. Those include the acetylcholine receptor [40], cytochrome
oxidase and the F1-ATPase [41,42] and band-3 erythrocytes [43]. In ad-
dition, it has been shown that dibucaine and tetracaine can alter the de-
naturation temperature of Ca+2-ATPase of sarcoplasmic reticulum [44].
Dibucaine and tetracaine inhibit the activation of mitogen-activatedprotein kinase mediated calcium channels [45] and also cause inhibi-
tions of dog kidney Na+, K+-ATPase activity [46] and G-protein couple
receptor signaling [47]. Local anesthetics were also found to affect
phospholipase D activity in differentiated human leukemic cells [48],
brain microtubule assembly and were capable of binding membrane
skeletal protein spectrin [50].
Brain spectrin, a protein homologous to erythroid spectrin, forms ﬁl-
amentous networks in the cytoplasmic face of the nerve cell membrane.
To establish its planer structure, it interacts with a large number of
proteins such as actin, adducin, ankyrin and band 4.1. Brain spectrin
remains most stable in its tetrameric state, formed by the side by side
association of the two heterodimers [51,52]. Like erythroid spectrin, it
also binds phospholipids [53].
In spite of so many studies discussed above, few attempts have been
made to study interactions of local anesthetics with other membrane
components e.g. cholesterol and ganglioside, GM1. Earlierwe have stud-
ied, using ﬂuorescence spectroscopy, the interaction of the protonated
quinoline-based local anesthetic, dibucaine, with small unilamellar ves-
icles of dimyristoylphosphatidylcholine (DMPC) and dioleoyl phospha-
tidylcholine (DOPC) containing different mole percents of cholesterol
and ganglioside [54,55]. We have extended the previous work using
another benzene-based, ﬂuorescent, tertiary amine local anesthetic,
tetracaine with small unilamellar vesicles (SUVs) of DMPC and DOPC
with or without cholesterol or the monosialoganglioside, GM1. As a
part of our broad objective towards building a workingmodel to under-
stand the mechanism of local anesthesia in the intercellular context we
also studied interactions of the protonated local anesthetics with brain
spectrin. In the present study, we show that, as tetracaine is known to
be less toxic and more potent than dibucaine, it interacts differentially
with the phospholipid membrane and the neuronal membrane skeletal
protein. This is reﬂected in differential membrane localization in the
presence and absence of cholesterol and GM1 and in the thermodynam-
ic parameters associated with binding to brain spectrin.
2. Materials & methods
Tetracaine hydrochloride, dibucaine hydrochloride, L-DMPC, L-DOPC,
cholesterol, diethylamine,MOPS, Tris, KCl, phenylmethylsulfonyl ﬂuoride
(PMSF), dithiothreitol (DTT), EDTA, EGTA, Imidazole, MgCl2, and NaCl
were purchased from Sigma (St. Louis, MO). Deionized water from
Milli-Q (Millipore Corporation, USA)was used for the preparation of buff-
er and all other solutions. Phospholipid concentrations were estimated
after digestion with perchloric acid following published protocol [56].
Stock solution of dibucaine and tetracaine was prepared in ethanol and
their concentrations were determined by absorbance measurement on a
Cary Bio-50 UV spectrophotometer using molar extinction coefﬁcient of
23,400 M−1 cm−1 at 310 nm for tetracaine and of 4400 M−1 cm−1 at
326 nm for dibucaine respectively [20,50].
Gangliosideswere isolated fromovine brain following the extraction
method elaborated in our previous work [55]. GM1 was prepared from
the ganglioside mixture by the treatment of neuraminidase at 37 °C
for 30 min to obtain the monosialogangliosides following the method
describe earlier [55,57]. GM1 was puriﬁed on DEAE Sephadex column
and the purity was checked by thin layer chromatography [55].
To prepare small unilamellar phospholipid vesicles (SUV) of DMPC
and DOPC, solutions of the phospholipids in chloroformwere ﬁrst evap-
orated under a thin stream of nitrogen. The resulting lipid ﬁlms were
then dried overnight in a vacuum desiccator. Lipids were swollen by
adding the buffer (10 mM MOPS, pH 6.5, containing 50 mM NaCl) to
the ﬁlms and the mixture of the lipid was dispersed using vortex. The
dispersion was then sonicated for 10 min (in bursts of 1 min while
being cooled in ice) using a Soniprep 150 sonicator from MSE, U.K.
The sonicated samples were centrifuged at 10,000 rpm for 15min to re-
move titanium particles. Cholesterol and GM1 containing vesicles were
prepared by co-solubilizing appropriate quantities of cholesterol and
GM1 with phospholipids in chloroform/methanol (2:1 v/v). SUVs of
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by electron microscopy showing average diameters within 250–350 Å.
Cholesterol and GM1 content in the membrane are expressed as mole
percent with respect to the bulk phospholipid.
Brain spectrin in its tetrameric form was puriﬁed from ovine brain,
in 10 mM Tris and 0.6 M KCl containing 20 μg/ml PMSF at pH= 8.0 fol-
lowing the published procedure elaborated in our previous work [58].
2.1. Steady state ﬂuorescence measurement
Small aliquots of an ethanolic stock solution of dibucaine and tetra-
caine hydrochloride were added to the standard buffer to obtain the
typical ﬁnal concentration of about 10 μM and 5 μM respectively for
ﬂuorescence measurements. Steady state ﬂuorescence measurements
of dibucaine and tetracaine were performed using Cary eclipse spectro-
ﬂuorometer at excitations of 325 nm and 311 nm with silts of 5 nm
bandpass both for excitation and emission channels respectively. The
tertiary amine-free vesicles were used as reference banks in absorption
and emission measurements to cancel any contributions due to solvent
Raman peak and other scattering artifacts. The spectral shifts obtained
from different sets of sample were identical in most cases, otherwise,
the values within ±1 nmwere reported.
Steady state anisotropy (r) measurements were performed using
Cary eclipse polarization accessory. Anisotropy values were calculated
from the following equation — [59]
r ¼ IVV−GIVH=IVV þ 2GIVH ð1Þ
where IVV and IVH are themeasured ﬂuorescence intensities with excita-
tion polarizer oriented vertically and horizontally respectively. G is the
grating factor and is the ratio of the efﬁciencies of the detection system
for vertically and horizontally polarized light and is equal to IHV/IHH. The
temperature dependence study of λmax of tetracaine in membrane
environments was carried out using a NESLAB RTE-110 circulating bath.
The apparent partition coefﬁcient (so-called because electrostatic
effects were not taken account) of dibucaine and tetracaine between
the membrane and the aqueous phases (Kp) was taken as the molar
ratio of lipid at which anisotropy Vs [L]/[D] or [L]/[T] plots changes
over from steeply increasing to saturation behavior [54,55].
2.2. Binding of dibucaine and tetracaine to brain spectrin
Small aliquots of an aqueous stock solution of dibucaine and tetra-
caine were added to 0.1 μM solution of non-erythroid spectrin upon
excitation at 295 nm in a buffer of 10 mM Tris and 20 mM KCl at
pH 8.0 for ﬂuorescence measurement. Protein free buffer containing
different concentration of anesthetic was used as blank in all ﬂuores-
cence measurements. Fluorescence intensities were corrected for the
inner ﬁlter effect, if any, due to absorption of the protein and the local
anesthetics, when absorbance, at both excitation and emission wave-
lengths, of the samples exceeded 0.05 [50]. Changes in the ﬂuorescence
emission intensity of proteins upon progressive addition of anesthetics
were measured to evaluate binding constants. Results from ﬂuoromet-
ric titration were analyzed by two different methods. The apparent
dissociation constant (Kd = 1/Kapp) of protein to anesthetic was
determined using non-linear curve ﬁtting analysis based on the
equation [50,58].
Pþ LA ¼ P−LA ð2Þ
where P represents protein and LA represents local anesthetic. All
experimental points for binding isotherms were ﬁtted by list square
analysis.
Kd ¼ ½Cs− ΔF=ΔFmaxð Þ  Cs  CLA− ΔF=ΔFmaxð Þ  Cs= ΔF=ΔFmaxð Þ  Cs ð3ÞCs  ΔF=ΔFmaxð Þ2− Cs þ CLA þ Kdð Þ  ΔF=ΔFmaxð Þ þ CLA ¼ 0 ð4Þ
ΔF is the change in ﬂuorescence intensity at 340 nm for each point of
titration curves. ΔFmax is the same when the ligand molecules are
completely bound to spectrin. CLA is the concentration of local anesthetic;
Cs is the concentration of the protein and Kd is the apparent dissociation
constant. The value of ΔFmax was determined from a double reciprocal
plot.
1=ΔF ¼ 1=ΔFmax þ 1=½Kapp  ΔFmax  CLA–CSð Þ ð5Þ
The linear double reciprocal plot of 1/ΔF against 1/(CLA − CS) is
extrapolated to ordinate to obtain value of ΔFmax. For monitoring the
anesthetics induced conformational changes of spectrin anisotropy
(r) were measured upon excitation at 295 nmwith the emission moni-
tored at 340 nm, as a function of increasing concentrations of the local
anesthetics.
All the measurements with membranes were performed at 35 °C
unless mentioned otherwise, with multiple sets of measurements. For
3 independent measurements, the average values are given. Error bars
for all spectrin binding experiments were given as standard errors of
mean (SEM) of 5 independent experiments.
2.3. Time-resolved ﬂuorescence measurements
Fluorescence lifetime was measured from the decay proﬁle of time
resolved ﬂuorescence intensity using Fluromax-3 spectrophotometer
(Horiba Jobin Yvon, Edison, NJ) with Data Station software in the time
correlated single photon counting mode using Nano-LEDs as source.
Lamp proﬁles were measured at the excitation wavelength using
powdered milk as the scattering control. To optimize the signal to
noise ratio, 5000 photon counts were collected at the peak channel.
All the experiments were performed in a buffer containing 10 mM Tris
and 20 mM KCl, pH 8.0 using excitation and emission slits with a nom-
inal bandpass of 4 nm or less. The excitation and emission wavelengths
were ﬁxed at 295 nmand340 nm respectively for determining the tryp-
tophan lifetime of brain spectrin. Fluorescence intensities decay curve
so obtained was deconvoluted with instrument response function and
analyzed as a sum of exponential terms:
F tð Þ ¼ ΣiαI exp −t=τið Þ ð6Þ
where F(t) is the ﬂuorescence intensity at time t and α is the pre-
exponential factor representing the fractional contribution to the
decay of the lifetime component such that Σiαi = 1. The goodness-of-
the-ﬁt to the data of a given set was evaluated by the χ2 ratio. A
ﬁt was considered acceptable when plot of weighted residue and
autocorrelation function showed random deviation about zero with a
minimum χ2 value not more than 1.20. Mean (average) lifetime (τ)
for triexponential ﬂuorescence decays were calculated from decay
times and pre-exponential factor using the following equation [59].
τ0 ¼ Σαiτi2=Σαiτi ð7Þ
2.4. Evaluation of thermodynamic parameters
The thermodynamic parameters for anesthetic binding with brain
spectrin have been determined from the van't Hoff equation:
ln Ka ¼− ΔH=RTð Þ þ ΔS=R ð8Þ
where Ka is the binding afﬁnity constant at temperature T and R is the
gas constant. The equation gives the standard enthalpy change (ΔH°)
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(ΔG°) has been estimated from the following relationship:
ΔG ¼ ΔH–T ΔS: ð9Þ
2.5. Circular dichroism measurements
CDmeasurements were carried out at room temperature in a Biologic
science spectropolarimeter. The spectra were scanned in a quartz optical
cell with path length of 0.1 cm. For monitoring changes in secondary
structure, all spectra were recorded with an increment in wavelengths
of 0.5 nm in the far UV region from 200 nm to 250 nm. Each spectrum
is an average of ﬁve continuous scans, corrected by subtraction of appro-
priate blank without spectrin. Spectrin (0.2 mg/ml) was incubated in a
buffer of 10 mM 20 mM KCl, pH 8.0 for 1 h with different concentration
of dibucaine/tetracaine before the spectra were recorded. All spectra
were smoothened making sure that the overall shape of the spectra
remains unaltered, expressed as observed value in millidegree. The CD
results have been analyzed in terms of mean residue ellipticity (MRE) in
deg·cm2·dmol−1 according to the following equation
θ½  ¼ θ½ obs mrwð Þ=10:c:l ð10ÞFig. 1. Change of intensity at emission maxima of tetracaine at 35 °C with phospholipid to tetra
20% (▲) Cholesterol and (b) pure (DOPC) (■); DOPCwith 20% (▲) and 40% (▼) Cholesterol. Ch
molar ratio ([L/D]) in SUVs composed of (c) pureDMPC (■); DMPCwith 10%(●) 20% (▲) Choles
& methods for other details.where c is the concentration of brain spectrin in g/ml, θ is observed rota-
tion in degree, l is the path length in cm, and μ is the mean residual mo-
lecular weight of spectrin. Quantitative assessment of the percentage of
α-helix in brain spectrin in the presence and absence of local anesthetic
could be estimated by the relation [60]
% of α−helix ¼ θ½ 222 þ 2340=−30300 ð11Þ
where [θ]222 are the observed MRE value at 222 nm. In Eq. (11), 2340 is
the MRE of the β-form and random coil conformation cross at 222 nm
and 30,000 is the pure helix at 222 nm.
3. Results
3.1. Tetracaine and dibucaine in phospholipid membrane containing
cholesterol
In aqueous environment (10 mM MOPS, 50 mM NaCl, pH 6.5)
protonated dibucaine (pKa = 8.3) and tetracaine (pKa = 8.5) show
emissionmaxima at 412 nmand 372 nmrespectively, whereas its emis-
sion progressively blue shifted in more hydrophobic environments.
Fig. 1 shows the changes in ﬂuorescence intensity of tetracaine and
dibucaine at the respective λmax, as a function of [Lipid/Anesthetic]caine molar ratio ([L/T]) in SUVs composed of (a) pure DMPC (■); DMPCwith 10% (•) and
ange of intensity at emissionmaxima of dibucaine at 35 °Cwith phospholipid to dibucaine
terol and (d) pure (DOPC) (■); DOPCwith 20% (▲) and 40% (▼) Cholesterol. SeeMaterials
825A. Chakrabarti, M. Patra / Biochimica et Biophysica Acta 1848 (2015) 821–832molar ratio in both DMPC and DOPC SUVs at 35 °C, well above the phase
transition temperature of both themembranes, with increase in choles-
terol. Tetracaine and dibucaine show opposite effect. The ﬂuorescence
intensity increased with increasing [L/T] for tetracaine in the absence
of cholesterol (Fig. 1a & b). Dibucaine, on the other hand showed
decrease in the intensity with increasing [L/D] both in the presence
and absence cholesterol (Fig. 1c & d), in DMPC and DOPC SUVs.
Fig. 2 shows the change in λmax as a function of lipid to tetracaine
molar ratio in DMPC (Fig. 2a) andDOPC SUVs (Fig. 2b) containing differ-
ent amounts of cholesterol at 35 °C. In pure DMPC vesicles λmax of
dibucaine appeared at 394 nm [54], whereas λmax for tetracaine ap-
peared at 354 nm from372nm indicating a blue shift of 18 nm. Incorpo-
ration of increasing amounts cholesterol in the DMPC vesicles had the
effect of progressively decreasing the extent of blue shift, with λmax
appearing at 401 nm and 368 nm for dibucaine and tetracaine respec-
tively, in the presence of 20% cholesterol ([L/A] N 500). Increasing the
cholesterol content from 0 to 40 mol% produced a signiﬁcant decrease
of the blue shift inλmax approaching the sameobserved in aqueous buff-
er. We had shown earlier that the λmax of quinoline based dibucaine is
blue shifted up to 30 °C beyondwhich it remained constantwith further
increase in temperature [54]. In case of tetracaine, the λmax was red-
shifted with increasing temperature up to 60 °C as shown in the inset
of Fig. 2b. Difference in the temperature dependence indicates deeper
incorporation of dibucaine than tetracaine at 25 °C in the liquid phase,
where tetracaine remains closer to the aqueous phase near the lipid
headgroups.
Fluorescence anisotropy probes the rigidity of the microenviron-
ment of the local anesthetic molecules through monitoring of theFig. 2. Variation of Wavelength at emission maxima (λmax) of tetracaine at 35 °C with
phospholipid to – tetracaine molar ratio ([L/T]) in SUVs composed of (a) pure DMPC
(■); DMPC with 10% (•) and 20% (▲) Cholesterol and (b) pure (DOPC) (■); DOPC with
20% (▲) and 40% (▼) Cholesterol. Inset show temperature dependence of ﬂuorescence
emission maxima of tetracaine in SUVs composed of pure DOPC (■, [L]/[T] = 400])
DOPC with 20% (•, [L/T] = 300) and 20% (▲, [L]/[T] = 200) Cholesterol. See Materials &
methods for other details.rotational dynamics of the ﬂuorophore. In our previous work we
showed that in aqueous solution protonated dibucaine exhibited a
small anisotropy (0.008 ± 0.02), implying unhindered rotation. Upon
incorporation in DMPC or DOPC SUVs large increase in anisotropy is ob-
served in dibucaine. Themaximum increasewas found in the absence of
cholesterol, the presence of which decreased the value of anisotropy
[54]. In contrast, the anisotropy value of protonated tetracaine was
very high (0.26) in bulk water which decreased to (0.21 ± 0.01) at
35 °C in both DMPC (Fig. 3a) and DOPC (Fig. 3b) SUVs with or without
cholesterol. The high anisotropy value of tetracaine in aqueous solution
indicates that the absorption and emission dipoles are almost parallel,
also observed in widely used molecules like diphenylhexatriene and
perylene-bis-amide [59]. The mean lifetime of tetracaine in aqueous
buffer yielded a very short lifetime of b50 ps compared to that of
dibucaine (2.7 ns).
The apparent partition coefﬁcient of dibucaine and tetracaine
between the membrane and the aqueous phase (Kp) was taken as the
molar ratio of lipid to anesthetics at which the anisotropy or the λmax
versus [L]/[D/T] plots changes over from steeply increasing or decreas-
ing to saturation (Figs. 2 & 3), as described in our previous work
[54,55]. Kp of dibucaine was estimated to be about 90, 75 and 55 in
DMPC and DOPC SUVs containing 0, 10 and 20% cholesterol respectively
(Table 1) at 35 °C [54,55]. Kp of tetracaine was found to be 2 to 3 times
higher than that of dibucaine (Table 1). The partition coefﬁcients for tet-
racaine were also measured according to the methods described by
Huang and Haugland [61]. In DOPC membranes Kp was estimated to
be 5.6 × 104 and 6 × 104 in absence and presence of 20% cholesterol,Fig. 3. Variation of steady state anisotropy of tetracaine at 35 °C with phospholipid to –
tetracaine molar ratio ([L/T]) in SUVs composed of (a) pure DMPC (■); DMPC with 10%
(•) and 20% (▲) Cholesterol and (b) pure (DOPC) (■); DOPCwith 20% (▲) and 40% (▼) Cho-
lesterol. See Materials & methods for other details.
Table 1
Estimates of apparent partition coefﬁcient (Kp) of the two local anesthetics in different
membranes with and without cholesterol or gangliosides.
Medium Dibucaine Tetracaine
DMPC 90 160
DMPC + 10% cholesterol 75 160
DMPC + 20% cholesterol 55 155
DMPC + 10% GM1 65 160
DOPC 125 180
DOPC + 20% cholesterol 110 175
DOPC + 40% cholesterol 75 175
DOPC + 10% GM1 80 175
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were 4.2 × 104 in absence and presence of 10% cholesterol. Estimation of
partition coefﬁcients by two independentmethods indicated that incor-
poration of cholesterol did not alter theKp of tetracaine or dibucaine. Al-
though cholesterol prevents entry of both tetracaine and dibucaine
deep into the hydrophobic core of the lipid bilayer, it only affects the
localization and not the partition coefﬁcient of the drugs, also with a
possible effect on the anesthetic potential of the molecules.
3.2. Tetracaine and dibucaine in phospholipid membrane containing
ganglioside
Nerve cell membranes are primary targets of local anesthetics and
these membranes contain 5 to 10% ganglioside of the total lipid mass.
We've carried out experiments on localization of protonated local anes-
thetics in phospholipid membranes with and without the ganglioside,
GM1 at 35 °C as described earlier [55]. Change in the λmax andFig. 4. Variation of wavelength at emission maxima (λmax) of tetracaine at 35 °C with phosphol
10% (▲) ganglioside and (b) pureDOPC (■);DOPCwith 10% (▲) ganglioside. Variation of steady
SUVs composed of (c) pure DMPC (■); DMPC with 10% (▲) ganglioside and (d) pure DOPC (■ﬂuorescence anisotropy of tetracaine as a function of lipid to drug
molar ratio in both DMPC and DOPC SUVs with and without 10% GM1
is shown in Fig. 4a, b, c, and d respectively. Incorporation of increasing
amounts of GM1 led to progressive increase in the extent of blue shift
of the λmax of dibucaine [55]. The λmax of tetracaine appeared at
354 nm in the absence and at 352 nm in the presence of 10% GM1
from that of 372 nm in aqueous buffer. Further blue shift in λmax of
both dibucaine and tetracaine indicates a deeper localization of the
local anesthetics in the presence of GM1 to more hydrophobic interior
of the membranes. Fig. 4c and d shows the variation of steady state an-
isotropy with increasing [L/T]. In the presence of 10% GM1 the anisotro-
py further increased from 0.09 in the absence to 0.116 [55]. However,
the anisotropy value of tetracaine remained unaltered in the presence
and absence of GM1 at 0.22. The apparent partition coefﬁcient also
remained same at 160 in the presence and absence of GM1.3.3. Binding of dibucaine and tetracaine to tetrameric brain spectrin
Brain spectrin shows the λmax at 338 nm upon excitation at 295 nm
and the addition of protonated dibucaine and tetracaine leads to
progressive quenching of tryptophan ﬂuorescence indicating formation
of spectrin-anesthetic complex (Supporting information Fig. 1). We
have estimated the apparent binding dissociation constant for such as-
sociation of brain spectrin and the local anesthetics following methods
elaborated in our earlier work [50,58]. Two representative binding
isotherms for both the anesthetics are shown in Fig. 5. The insets in
Fig. 5 show the representative double reciprocal plot of 1/ΔF against
1/(CLA − CS) from which the binding constants were evaluated. The
binding dissociation constants and stoichiometry show the bindingipid to tetracaine molar ratio ([L/T]) in SUVs composed of (a) pure DMPC (■); DMPC with
state anisotropyof tetracaine at 35 °Cwith phospholipid to tetracainemolar ratio ([L/T]) in
); DOPC with 10% (▲) ganglioside. See Materials & methods for other details.
Fig. 5.Plot of the extent of anesthetic induced quenching vs. concentration of dibucaine/tetracaine for the evaluation of dissociation constant of the association of dibucaine/tetracainewith
brain spectrin. See Materials & methods for other details.
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the bulkier dibucaine than tetracaine, as summarized in Table 2.
3.4. Evaluation of thermodynamic parameters for the association of brain
spectrin with local anesthetics
Thermodynamic parameters associated with the binding of
dibucaine and tetracaine with spectrin e.g. changes in the ΔG, ΔH and
ΔS were determined from the van't Hoff plots of lnKa versus 1/T, as
shown in Fig. 6 and summarized in Table 3. The ΔG value is negative
indicating the process to be spontaneous. Formation of the anesthetic–
spectrin complexwas found to be exothermicwith large positive chang-
es in ΔH and ΔS suggesting hydrophobic interactions to play a key role
in the molecular reorganization process.
3.5. Differential effects of dibucaine and tetracaine on brain spectrin
Further evidences of the binding of the local anesthetics with brain
spectrin were obtained by measurements of anisotropy of tryptophan
ﬂuorescence and excited state lifetime. Steady state anisotropy of tetra-
meric brain spectrin is 0.13 ± 0.2 implying the localization of trypto-
phan residues in conserved region which remained more or less
unchanged in the presence of increasing concentrations of protonated
dibucaine, as shown in Fig. 7. In contrast, the anisotropy of the protein
sharply decreased with increasing concentrations of protonated tetra-
cainewhichmight be attributed to the fact that binding of tetracaine in-
duces structural changes in brain spectrin causing release in rotational
motion of the Trps. To further validate this result, we have done
time-resolved ﬂuorescence measurements with brain spectrin in the
presence and absence of the two local anesthetics (Supporting informa-
tion Fig. 2). Here again the mean lifetime of spectrin changed only
marginally from 3.80 ns to 3.95 ns in the presence of dibucaine. On
the other hand, the mean lifetime decreased substantially to 3.20 ns in
the presence of tetracaine (Table 4).Table 2
Binding dissociation constant for the interaction of dibucaine and tetracaine with brain
spectrin in 10 mM Tris and 20 mM KCl at pH= 8.0 at 25 °C.
Ligand Binding dissociation constant (μM) Binding stoichiometry (n)
Dibucaine 0.246 ± 0.12 180 ± 20
Tetracaine 0.4705 ± 0.18 100 ± 203.6. Effects of local anesthetic on conformational changes of brain spectrin
monitored by CD spectroscopy
CD spectra of brain spectrin showed two negative bands in the far
UV region at around 208 nm and 222 nm, characteristic of a typical α-
helical protein (Fig. 8). Both bands are attributed to n− π* transition
for the peptide bond of the α-helical protein [62]. The CD spectrum of
brain spectrin remains unaltered in the presence of protonated
dibucaine. However, in the presence of protonated tetracaine the CD
spectrum changes signiﬁcantly without any shift in the peak positions
indicating partial changes in the secondary structure of spectrin upon
binding to tetracaine. Our results show that free spectrin contains
about 89% α-helical structure which increased to 95% at molar ratio of
tetracaine to brain spectrin of 200:1. The increase in theα-helical struc-
ture of a protein upon binding to drug molecule has also been reported
previously for diomestin-HSA adducts [63].Fig. 6. Van't Hoff plot of for the interaction of brain spectrin (0.1 μM) with (■) dibucaine
and (□) tetracaine in 10 mM Tris 20 mM KCl pH = 8.0. See Materials & methods for
other details.
Table 3
Thermodynamics parameters for the interaction of dibucaine and tetracaine with brain
spectrin in 10 mM Tris and 20 mM KCl at pH= 8.0.
Ligand ΔH
(k-cal mole−1)
ΔS
(e.u.)
ΔG
(k-cal mole−1)
Dibucaine 11.42 63.06 −7.253
Tetracaine 9.45 53.09 −6.482
Table 4
Fluorescence lifetime components of brain spectrin in the absence and presence of local
anesthetic.
Sample τ1
(ns)
τ2
(ns)
τ3
(ns)
A1 A2 A3 τ
(ns)
χ2
Brain spectrin 1.27 4.08 0.230 0.272 0.676 0.05 3.80 1.06
Brain spectrin +
dibucaine
1.25 4.156 0.367 0.176 0.784 0.03 3.95 1.00
Brain spectrin +
tetracaine
0.731 3.44 0.09 0.369 0.592 0.03 3.20 1.05
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Artiﬁcial membranes are widely used as a model system for the
elucidation of biological processes that occur in the biological mem-
brane along with different applications in biotechnology [64–66]. In
pharmaceutical research, biological membranes act as drug delivering
vehicles and interact with membrane associated protein such as ion
channel, receptor etc. to exert their function [67]. Local anesthetics,
such as dibucaine, tetracaine and other amphipathic amines could
interact with lipids andmodulate states of the sodium channel, favoring
the inactivated form, partitioning within and permeate through the
lipid bilayer [3,4]. Thus it is important to understand intrinsic interac-
tions between the drug molecules and lipid membranes in controlling
the rate limiting step for dissociation of the drug into the target protein.
Dibucaine and tetracaine along with other tertiary amine local
anesthetics have been extensively studied previously using various
spectroscopic and calorimetric methods [19–26,28–33]. However, the
mechanism of local anesthesia and membrane localization of these an-
esthetics is still not well-known. In this paper we have studied the
membrane localization of dibucaine (pKa = 8.3) and tetracaine
(pKa = 8.5) the two well-known protonated monocationic tertiary
amine local anesthetics in the presence and absence of two important
membrane components cholesterol and GM1 in phospholipid mem-
branes using ﬂuorescence spectroscopy. We have also considered the
role, if any, of membrane skeletal proteins e.g. brain spectrin, in
the overall mechanism of anesthesia upon translocation across the
membrane bilayer, facilitating the entry of the cationic drug into the
cell. Several studies have been done to explore the mechanism of
membrane interactions of the local anesthetics. In a few studies high
concentrations of local anesthetics have been used which caused mem-
brane disruption and irreversible nerve injury [5,68]. Concentrations of
charged dibucaine and tetracaine (b20 μM) used in this study are closeFig. 7. Variation of steady state anisotropy of brain spectrin tryptophan with increasing
concentration of dibucaine (□) and (●) tetracaine. See Materials & methods for other
details.to the concentration used as ion channel blocker. High concentration of
local anesthetics changes phase transition temperature and bulkﬂuidity
of formation of anesthetic-lipid mixed micelles [69,70]. On the other
hand, at local anesthetics concentration between 1 and 10 μM, used
in this study, there would be only 1 local anesthetic molecule per
500–10,000 lipids and the effect of local anesthetic on the phase behavior
of the bulk bilayer properties at this stoichiometrywould be insigniﬁcant.
The increase in the ﬂuorescence intensity of protonated tetracaine
and decrease of cationic dibucaine in the presence of increasing phos-
pholipids indicated differential partitioning of both dibucaine and tetra-
caine from the aqueous to the membrane phase. This could be
attributed to the difference in the hydrophobic clusters of their primary
emitting chromospheres — quinoline for dibucaine and para-amino
benzoate for tetracaine. Above the main phase transition temperature
of DMPC (Tm at 24 °C) andDOPC (Tm at−18 °C) the partition coefﬁcient
did not change signiﬁcantly up to 20% cholesterol, which is in general
agreement with our earlier work [54]. The partition coefﬁcients for
tetracainewere about 6× 104 in DOPC SUVs containing 0% and 20% cho-
lesterol and 4× 104 inDMPCvesicles containing 0% and 10% cholesterol.
Similar changes in apparent partition coefﬁcient of both protonated
dibucaine and tetracaine in GM1 containing membranes were also ob-
served [54,55]. This trend of change of apparent partition coefﬁcients
of both the local anesthetics indicates that inclusion of cholesterol or
ganglioside brings about conformational rearrangements of dibucaine
and tetracaine inside the core of the bilayer without affecting the parti-
tion equilibrium.
The neutral form of dibucaine emits from its lowest singlet n,Π* state
when protonated; the relative position of its n, Π* andΠ, Π* states are
interchanged [71]. In aqueous buffer, emission ofmonocationic dibucaine
is thus due to theΠ,Π* single transition, whereas in phospholipid mem-
branes the equilibrium shifts towards neutral dibucaine, and emission
thus takes place due to n,Π* transition. Since inter-system crossing prob-
ability is lower forΠ,Π* than for n,Π* transitions, the emission quantum
yield is higher in the former. No such state reversal is expected to occur forFig. 8. Far UV CD spectra of brain spectrin alone and in the presence of 25 μM dibucaine
and tetracaine respectively. See Materials & methods for other details.
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ate and emission occurs from the lowestΠ,Π* singlet states.
Earlier NMR and ﬂuorescence spectroscopic studies have shown that
dibucaine binds in the vicinity of the phospholipid glycerol moiety
[21,36–38]. This has been conﬁrmed by recent solid state NMR studies,
placing the quinoline ring near the glycerol motif of phospholipids
[72,73]. Using deuterated phospholipids Boulanger and coworkers
showed that tetracaine resides near the polar head group of phospho-
lipids causing an ordering of the head group, an observation also con-
ﬁrmed by Watts and Poile using quadruple splitting of methylenes
group of the PC head group [20,24]. NMR studies on the interaction of
tetracaine with DMPC membranes containing 30% cholesterol together
with our previous ﬂuorescence work showed that both tetracaine and
dibucaine localize close to the aqueous interphase in the presence of
cholesterol [39,54]. A relatively recent study indicates that both charged
and neutral tetracaine localize at the same place in phosphatidylcholine
based membranes both in the absence and presence of cholesterol [74]
although previous NMR studies of Boulanger and coworkers proposed
that two ionization states of tetracaine occupy distinct locations in the
bilayer [20]. The changes in the extent of blue-shift in the λmax from
372 nm to 354 nm for protonated tetracaine and from 412 nm to
394 nm for protonated dibucaine in both DMPC and DOPC membranes
reveal that both the species reside in the hydrophobic interior of the
membranes. The presence of cholesterol brings about similar effects
for tetracaine at 35 °C as that for dibucaine, leading to displacement
from the interior of the bilayers, towards the interface [54]. In other
words, the presence of cholesterol inhibits the penetration of the local
anesthetic molecules deep into the bilayer. The results are consistent
with the NMR studies on localization of tetracaine that suggest deeper
partitioning in the pure DMPC bilayer while the presence of 30% choles-
terol squeezed it closer to the aqueous interface of the bilayer [54,39].
Further changes in the extent of blue shift of λmax of tetracaine in the
presence of GM1, on the other hand, point to localization in the hydro-
phobic core of the phospholipid bilayers as observed in dibucaine [55].
An important aspect of the results reported here is the marked
difference in ﬂuorescence properties of protonated dibucaine and tetra-
caine in membranes with and without cholesterol. For example, the
quantum yield of dibucaine in the DMPC membrane is ~40% lower
than in water whereas that of tetracaine is enhanced by ~5 fold. The
steady state anisotropy of dibucaine is expectedly higher in the interior
of membranes than in bulk water; however, that of tetracaine is
somewhat lower in membranes. We also found that the anisotropy of
dibucaine was further increased in the presence of GM1 when that of
tetracaine remained almost the same in DMPC membrane with GM1.
Binding and partitioning of local anesthetics into the phospholipid
membranes are controlled by both hydrophobic and ionic interactions.
Hydrophobic forces are the major factor for partitioning of the local an-
esthetics in the core of the phospholipid bilayer. However, the interfa-
cial ionic components of the membrane head groups also play a
crucial role for such partitioning. NMR studies have demonstrated that
dibucaine and tetracaine are located closer to the head group than to
the center of the hydrocarbon chains and the charged form of tetracaine
is effective in changing the conformation of the phospholipid head
groups [38,75,76]. The magnitude of this latter effect depends on the
phase behavior of the phospholipids and the charge of the anesthetics.
Thus incorporation of local anesthetics in model membrane causes
alteration of interfacial charge density leading to conformational
rearrangements of phospholipid head groups. This results in the de-
crease in the rotational mobility which is reﬂected in the increase in
ﬂuorescence anisotropy. Upon interaction of local anesthetics with the
hydrocarbon region of the membrane, a rearrangement of the intramo-
lecular hydrogen bonding network between the phospholipid
molecules takes place, associatedwith the liberation of watermolecules
from membranes. Fluorescence studies of Yun and coworkers also
showed that this kind of dual effect could explain the decrease in
rotational mobility at the membrane surface and the increase in therotational mobility in the interior hydrocarbon core of the bilayer, in
both model and native membrane systems [27–29]. Fraceto and co-
workers proposed that perturbing efﬁciency of a local anesthetic does
not correlate well with hydrophobicity alone. Using ESR, NMR and ﬂuo-
rescence spectroscopy they have shown that lidocaine, a lesser hydro-
phobic molecule, led to marked decrease in membrane organization
compared to more hydrophobic local anesthetics indicating polar inter-
actions, steric parameters and the free volume generated by the hydro-
phobic mismatch between the local anesthetic and phospholipids
which together determine membrane structural defects [30,31]. Our
ﬂuorescence data suggest that dibucaine penetrates the lipid bilayer
and remains in the vicinity of the glycerol backbone region of the phos-
pholipid molecule, acting as a spacer. Dibucaine is a spherical molecule
and the presence of two aromatic rings creates steric hindrance for its
insertion between lipids allowing the charged anesthetic molecule to
take part in electrostatic interaction between the positive charge on
choline nitrogen and the phosphate groups of the adjacent lipids. An
extra volume of dibucaine creates extra space in between lipids and al-
ters interfacial charge density leading to conformational rearrange-
ments of phospholipid head groups and changes in the hydration
patterns. This creates a more hydrophobic environment within which
lipids are less associated to water interacting more strongly to
dibucaine, restricting its rotational motion and thus leading to higher
anisotropy. On the other hand, tetracaine is an amino-ester local anes-
thetic that does not have cyclic aromatic moiety, assuming a cylindrical
shape with a long amino butyl tail in the para position of the benzoic
acids ring. Due to smaller size and higher charge density, tetracaine be-
haves like an inorganic ion affecting the head group conformation. The
physical insertion of charged tetracaine molecules between the lipids
and electrostatic interaction between phospholipids and the anesthetic
dimethylamino moieties could together be responsible for altering the
existing intra and intermolecular interactions. This is reﬂected in the
emissionmaximawhenmeasured at different temperatures, suggesting
that the charged portion of tetracaine is located close to the polar head
group region of the bilayer with the akyl chain descending in the acyl
chain region. Such residence of tetracaine causes the ordering of the
phospholipid head groups altering the inner hydrogen bonding net-
work between phospholipids. This leads to an increase of gauche
rotamers, further increasing the disordering in the membrane surface
area causing a decrease in the ﬂuorescence anisotropy.
The interactions between cholesterol and phospholipids have been
extensively studied and are known to affect the phase transition be-
tween the liquid crystalline and the ripple gel phase of phospholipid
membranes [18,77]. From the temperature dependence study, we
have seen a progressive red-shift of the λmax with increasing tempera-
ture, opposite to that of dibucaine [54]. The presence of cholesterol
causes an expansion between the acyl tails of phospholipids and perturb
of dipole–dipole interaction between the charged anesthetics and the
phospholipids in the interface region. Perturbation of dipole interac-
tions in the interfacial region is smaller compared to the same in the
acyl tail region, preventing anesthetic molecules from penetrating
deep into the inner core of the hydrophobic region. This is also consis-
tent with our earlier observations with dibucaine localizing closer to
the phospholipid head groups in the presence of cholesterol [54]. The
membrane localization of protonated dibucaine and tetracaine is almost
similar, in the presence and absence of cholesterol. However, the differ-
ence in localization, reﬂected in the changes in ﬂuorescence anisotropy,
and in the temperature-dependent variation of λmax only depended on
the change in membrane ﬂuidity induced by the two local anesthetics.
Similar differential interactions are also feasible with target proteins
such as the sodium channel, giving rise to difference in anesthetic poten-
cies between the benzene based and the quinoline based compounds.
Brain spectrin is a homologue of erythroid spectrin that remains
mainly in its tetrameric from. It has a large number of tryptophan resi-
due distributed along the entire length of the protein [50,53]. The
most interesting structural feature is that although it has a large number
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of each domainmaking them convenient intrinsic ﬂuorescence reporter
groups for monitoring conformational changes in the protein that
contributes to its elastic deformability exhibited under physiological
conditions. The ﬂuorescence lifetime decay proﬁles of brain spectrin,
in the presence and absence of both protonated dibucaine and
tetracaine are shown in Supporting information Fig. 2. The lifetime com-
ponents and theﬁttingparameters are summarized in Table 3. The three
individual lifetime components of the tryptophan of the native spectrin
were 1.27, 4.08 and0.23 ns respectivelywithmean lifetimeof 3.80 ns. In
the presence of tetracaine the longer lifetime component decreases
from 4.1 ns to 3.4 ns and the mean lifetime also decreases from 3.8 ns
to 3.2 ns.
Fluorescence and CD studies indicate binding of protonated
dibucaine and tetracaine to tetrameric brain spectrin. Binding dissocia-
tion constants are similar and independent of the size of the ligands. An
estimate of the binding stoichiometry indicates about 200 molecules of
dibucaine and 100 molecules of tetracaine to be associated with one
tetrameric brain spectrin. Binding sites of both the ligands are near tryp-
tophan residues in each repeat domain and resonance energy transfer
between the local anesthetics and the tryptophan residues are indicated
to be one of the most possible mechanisms through which the
quenching takes place. Although the binding afﬁnity of the protein
with both the anesthetics is (104 M−1) not strong enough, the normal
prevalence of brain spectrin is high enough to permit such conjugation.
Knowledge of the thermodynamic parameters such as changes in free
energy, enthalpy and entropy helps in the understanding of the
molecular basis of the interactions between brain spectrin and the
local anesthetics. Ross and Subramanian have characterized the sign
andmagnitude of thermodynamic parameters in various types of inter-
actions associated with protein–ligand interactions [78,79]. From the
thermodynamic point of view positive changes of both ΔH andΔS indi-
cate strong hydrophobic interactions whereas negative changes of both
indicate the predominance of hydrogen bonding or van derWalls force.
For the electrostatic interactionsΔH is often negative andΔS is positive.
The present case of local anesthetics binding to brain spectrin is associ-
ated with positive ΔH and ΔS suggesting that hydrophobic interactions
play a key role. Favorable positive entropic contribution due to release
of protein bound water molecules favors the association when both
the ligands bind to brain spectrin. In physiological pH both the ligands
remain in charged and uncharged forms, the charged and uncharged
parts of the anesthetic molecule binds to charged and neutral side
chain of the amino acid residues in brain spectrin without affecting
the helices. This leads to the release of the protein-bound water
molecules and provides the necessary entropic source of the binding.
CD spectra of brain spectrin showed two negative bands in the
far UV region at around 208 nm and 222 nm, characteristic of a typical
α-helical protein and both attributed to n− π* transfer for the peptide
bond ofα-helical protein [60,62]. Change in absorbance in the CD spec-
trum of brain spectrin in the 190–250 nm region in the presence of both
the protonated local anesthetics suggests that dibucaine association
does not perturb the helical backbone structure of spectrin. But the
ellipticity at 222 nm increased signiﬁcantly in the presence of tetracaine
indicating structural perturbations in the secondary structure of
spectrin. More attention needs to be directed to the fact that proteins
usually serve as vectors for almost all endogenous and exogenous li-
gands to ship the ligands to their target where it elicits its functions.
These features of the interaction imply that interaction of local anes-
thetics with brain spectrin together with the membrane localization
could be taken into account for an understanding of the mode of action
of the local anesthetics in vivo.
One interesting aspect of the present work is that the tryptophan
anisotropy decreases in brain spectrin upon increasing concentrations
of protonated tetracaine and the mean lifetime is also lowered upon
binding tetracaine. Both anisotropy and mean lifetime remain un-
changed upon spectrin binding of protonated dibucaine. Thisdifferential behavior further indicates that the benzene-based local an-
esthetic could induce large conformational changes in spectrin. Similar
results were earlier reported with other benzene-based local anes-
thetics, lidocaine and procaine, inducing such conformational changes
in cytoskeletal proteins [80,81]. Using light scattering techniques on
themodelmembrane Kitagawa et al. reported that local anesthetics dis-
play detergent-like properties and can disrupt the model membrane.
Such detergent-like properties are also the cause of irreversible injury
caused by lidocaine and tetracaine when used in higher concentrations
[5]. Studies of the effects of procaine, tetracaine and dibucaine on the
polymerization–depolymerization behavior of microtubules indicate
similar differential behavior of benzene based procaine and tetracaine
as that of quinoline based dibucaine. While procaine and tetracaine
were found to increase the rates of tubulin polymerization at 24 °C
and of microtubule depolymerization at 4 °C as a linear function of the
concentration of the local anesthetics, dibucaine, on the other hand,
showed a linear decrease in the tubulin polymerization andmicrotubule
depolymerization rates [49].
Koudra and co-workers proposed that the aromatic ring in the local
anesthetic not only confers lipophilicity allowing its passage through
the membrane, but also for Π-stacked binding with the phenyl group
of the phenylalanine residue of the Na+ channel inactivating peptides
MP-1 and MP-2 [2]. They have proposed the molecular mechanism of
local anesthesia using dibucaine, indicating that it locates at the polar
head region of the boundary lipids in the vicinity of the Na+ channel, in-
teracts throughΠ-stacking face to face, also interactswith the phenylal-
anine residue allowing its protonated quaternary nitrogen to interact
electrostatically with negatively charged amino acid residue of the
peptide. Their activity depends on the optimal distance between the
aromatic ring and the tertiary amine nitrogen. Taken together, our re-
sults also indicate that both charged dibucaine and tetracaine remain
in the vicinity of the polar head region of the phospholipids to interact
with the Na+ channel in its inactive state. Previously Paula and his
co-workers demonstrated that steric factor, location and orientation of
anesthetics in themembrane play a crucial role in themechanism of an-
esthesia [30,31], since they can modulate local anesthetic-Na+ channel
binding by directing the molecule to access the proper site of the chan-
nel. Our results also indicate factors like shape, size, orientation and
location of the local anesthetics in the phospholipid membrane and
steric effects arising out of a mismatch between the anesthetics and
phospholipids. These may be the origins of differential anesthetic po-
tential between dibucaine and tetracaine in terms of interactions with
components of neuronal membrane lipids and the skeletal protein,
spectrin.
5. Conclusion
Earlier NMR and ﬂuorescence studies indicate that both dibucaine
and tetracaine bind in the vicinity of the glycerol backbone of phospho-
lipids [19–26,35–38]. Recent ﬂuorescence studies show that neutral an-
esthetic tetracaine partitioning into themembranes more strongly than
the cationic form of the anesthetic but the location of both forms re-
mains the same [74]. At physiological pH the local anesthetics remains
as a mixture of both cationic and neutral forms. The extent of
partitioning of neutral form of tetracaine is about 6 times more than
its cationic form whereas in case of dibucaine the extent of partitioning
of both forms is almost similar. NMR and ESR studies indicate that the
penetration of dibucaine into the lipid membrane is inﬂuenced by the
steric factor [30,31]. Moreover electrophysiological data shows the im-
portance of uncharged and smaller local anesthetic molecules e.g. tetra-
caine and lidocaine in permeating from extracellular space to the
cytoplasmic compartment, to ﬁnally block the sodium ion channel by
its inactive state [3,4]. The present ﬂuorescence study indicates that
both protonated dibucaine and tetracaine exist in the membrane inter-
face. Tetracaine localizes closer to the aqueous phase anddibucainenear
the glycerol backbone of phospholipids, also shown by 1H MAS NMR
Fig. 9. Cartoon diagram showing possible localization of the local anesthetics in phospholipid bilayer.
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of both the local anesthetics, however, the presence of GM1 enhances the
penetration of the drugs into the hydrophobic core of the lipid bilayer.
Considering all these observations, one could conclude that in physiolog-
ical pH the cationic tetracaine binds strongly to the negative phosphate
groups of the membrane phospholipids whereas dibucaine binds more
weakly than tetracaine and enters into the more hydrophobic glycerol
backbone of the phospholipids. Due to its smaller size and stronger inter-
actionwith phosphate groups, tetracaine induces conformational chang-
es at membrane interface accompanied by disordering of the fatty acyl
chain region. This in turn increases the area of membrane cross section
and allows entry of neutral tetracaine from the extracellular face to the
cytoplasmic compartment of the cell in assistance with membrane skel-
etal proteins and promotes Na+ ion channels to remain in an inactive
state induced by membrane depolarization, shown in Fig. 9.
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